Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. - Wikidata - awgldk - TriplyDB

Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.

Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.

http://www.wikidata.org/entity/Q36022696

about

High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas Head and neck rhabdomyosarcoma: follow-up results of four cases and review of the literature Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting Cytotoxicity of activated natural killer cells against pediatric solid tumors.Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS Outcomes for children and adolescents with cancer: challenges for the twenty-first century.MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas.Imaging findings in craniofacial childhood rhabdomyosarcoma.Rhabdomyosarcoma: current challenges and their implications for developing therapies.A novel algorithm for simplification of complex gene classifiers in cancer.Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group.Epidemiology and therapies for metastatic sarcoma Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcoma Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group Challenging issues in pediatric oncology Do characteristics of pulmonary nodules on computed tomography in children with known osteosarcoma help distinguish whether the nodules are malignant or benign?Rhabdomyosarcoma of the head and neck in children Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas Inhibition of metastasis of rhabdomyosarcoma by a novel neutralizing antibody to CXC chemokine receptor-4.The clinical, research, and social value of autopsy after any cancer death: a perspective from the Children's Oncology Group Soft Tissue Sarcoma Committee.Clinicopathological characteristics and treatment outcomes of Chinese patients with genitourinary embryonal rhabdomyosarcoma.CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker.Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report.A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases.Overcoming autopsy barriers in pediatric cancer research.Higher rates of metastatic disease may explain the declining trend in Swedish paediatric rhabdomyosarcoma survival rates.Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.Breast relapse after metastatic alveolar rhabdomyosarcoma: Is it an incurable entity?A Case of Long-term Survival of Advanced Paratesticular Rhabdomyosarcoma Treated With a Multimodal Therapy Including a Combination of Cyclophosphamide, Vincristine, Doxorubicin and Dacarbazine Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells Orbital rhabdomyosarcomas: A review.

P2860

Q24235604-77FD0765-3C0D-4616-A4C8-D86E472465C1 Q26782842-2417F57D-C09F-4136-AF3C-401174AF5512 Q26801952-186E3019-AF15-47D9-95DF-0DFB3B911E11 Q26825000-8E58ADA4-E79C-4000-9532-2E899FF1598C Q27026347-15680F3E-F465-4C25-BE63-16B5F2C9F25F Q30009946-360E0A78-EDE7-4C4E-9DF8-46488E58EE7F Q30426842-FD7CE9CE-1BAD-4902-A055-B98126BD1223 Q30503995-528B6B1E-9F10-4555-8AD6-0D720F93EFBF Q33559468-0A0F1AFE-B8E7-4E9E-8C6C-320A4C2E5ADE Q33592489-B93DEDDE-9131-4943-8BD7-933AE8BB25F5 Q33897659-E45269A7-D7C5-43AC-95C5-C34A4389B64F Q33906031-D8C2BF82-AB7E-4870-9CAB-A11F2C523CF6 Q34176966-54D22FF4-D075-4668-A9C0-EC138EB0204F Q34400242-6BFA6021-1346-476D-94FD-6E9E257EC105 Q34520679-2A8AE2C8-4549-4E15-AE5F-231206B432CC Q34578460-7592420D-3F8D-4BB9-8171-C710DC9B24B1 Q34652142-656C79D2-9809-4F05-A6AE-746627E19B81 Q34688987-23BAA6AA-365D-460D-8906-57DC274D4562 Q34706841-68462B06-CCE8-43A7-BE27-9E6B9BFE6D8C Q34879284-092CF205-3C6A-4A63-9405-D2D8849E6ED6 Q35602419-DE9DB47C-3E6B-4AE5-A29E-50992ED84186 Q35646332-C88B3581-6BC9-4C36-AE40-35611B4973D5 Q35648994-DEED2DAD-020D-4470-968E-A12C3903DB3E Q35683306-A61A642E-80E0-49D7-9DF2-A12DC7D89C2A Q35713242-4D98E0E4-ADDD-4F41-99BA-0D2D6E3902B5 Q35742899-6FCDE3B8-7BC2-481C-A57E-5A9E1B22F49E Q35762410-184892F5-AA6B-452C-811D-321F49F08D04 Q36030949-B1FEC835-15CE-484E-B7AE-B87B1BCCE991 Q36084235-4E3C1D61-8D49-4D09-B914-F280163EF2C6 Q36191943-0070E7AB-6660-43FB-9522-F46F130FE8EE Q36283044-249A7472-E2EF-4485-88E3-1AF32D0B7CAE Q36460093-C84631EE-87A8-40C8-B3A8-6C084DD42EE8 Q36468017-0D991FBD-908D-48AF-A3BF-B0D300BEB945 Q36536619-ADEC2C6C-62F7-45FD-8B78-E08D71208DF4 Q36592140-00C1EAAC-929C-4635-B549-5140302D581D Q36861423-42EA834E-DCBD-42C2-8BD3-D679B065955B Q37009067-ED00DB82-3696-443A-9AE3-6C1EBFA93B46 Q37029379-408AC763-DF4B-4D56-94AF-1E6F9DC8E3D4 Q37049062-8F005727-B343-49D9-8BA9-54E923D12601 Q37163456-50BA0816-1918-4C64-B93E-68105657DE32

P2860

Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.

http://www.wikidata.org/entity/Q36022696

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Prognostic factors in metastat ...... d European cooperative groups.

@ast

Prognostic factors in metastat ...... d European cooperative groups.

@en

type

label

Prognostic factors in metastat ...... d European cooperative groups.

@ast

Prognostic factors in metastat ...... d European cooperative groups.

@en

prefLabel

Prognostic factors in metastat ...... d European cooperative groups.

@ast

Prognostic factors in metastat ...... d European cooperative groups.

@en

P1433

Q36022696-8A5FC825-99D9-45F8-95DF-A624B115AD0B

P1476

Q36022696-CDD5B150-ACF6-4F83-91D6-2FDB14396B31

P2093

Q36022696-19BB9644-6A95-44DE-BC44-7D67441FA97D

Q36022696-9A5EA688-6F58-4038-ABEE-157EE8C7BA01

Q36022696-CCEB9348-B5FA-475F-8C1F-960FBD88A8C9

Q36022696-D81FBD65-7DCE-45EC-AFA6-381A804E338F

Q36022696-F6389154-6298-4177-A818-5650975DF3BB

Q36022696-F6C8E022-27D4-460F-A098-EA14841FD6F8

P2860

Q36022696-1914B210-4FA0-4881-8D6E-012D05350EBA

Q36022696-22C4DF75-8E36-4FB1-9BA9-FD3F0AF72E3F

Q36022696-26ACB8AA-1848-4491-994F-47ADB2A71FBA

Q36022696-2D446055-EB1F-4EB6-A732-D68B7E480A18

Q36022696-2F396CC9-2589-421D-99D1-A0DEC7E9608E

Q36022696-48297C89-CFFE-4020-B392-C79A0985FA53

Q36022696-51EF83F2-0B64-4306-B456-FC45C4E61B81

Q36022696-57449E92-6AE6-4096-9AE2-2B6742FBF2D6

Q36022696-5B6EC2F3-F996-4AE4-9477-AF8F1FFDBE12

Q36022696-7F86C66A-F157-4C70-9530-1BAE8206AFA3

P304

Q36022696-74F5C9A1-C585-4F99-9DF3-1E89923BE872

P31

Q36022696-A35C7BF6-3B91-4182-A7FC-9BA9D6951212

P356

Q36022696-479A7A5F-EC99-4976-B2EE-4B85F1B6A0A7

P407

Q36022696-7EC5D680-4A89-4532-9DF2-5AD72A42F467

P433

Q36022696-21C9B170-16B3-418B-A3B1-5573B4A6F406

P478

Q36022696-FB0CE505-7EDE-4B8E-B3D2-1956F4BD2246

P50

Q36022696-484E255F-B47A-4312-A61E-DF5C885C49BA

Q36022696-5817C862-C803-41DC-A2CE-FA0F9A875F88

P577

Q36022696-7549DD61-7977-4FE4-80CE-A6936A1AC02E

P698

Q36022696-A969BBB5-77FE-4960-90AC-F0C07A629EA8

P921

Q36022696-D38BFCAF-E94D-4BB3-9C9A-39CA09F0C41D

P932

Q36022696-B39B1229-3E45-43C6-9856-652E7331E6B3

P356

JCO.2007.14.7207

P1433

Journal of Clinical Oncology

P1476

Prognostic factors in metastat ...... nd European cooperative groups

@en

P2093

Annie Rey

http://www.w3.org/2001/XMLSchema#string

Elizabeth Lyden

http://www.w3.org/2001/XMLSchema#string

James R Anderson

http://www.w3.org/2001/XMLSchema#string

Modesto Carli

http://www.w3.org/2001/XMLSchema#string

Odile Oberlin

http://www.w3.org/2001/XMLSchema#string

William H Meyer

http://www.w3.org/2001/XMLSchema#string

P2860

Disease patterns and survival rate in children with metastatic soft-tissue sarcoma. A report from the Intergroup Rhabdomyosarcoma Study (IRS)-I.

Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study.

Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.

Response of previously untreated metastatic rhabdomyosarcoma to combination chemotherapy with carboplatin, epirubicin and vincristine.

Evaluation of survival data and two new rank order statistics arising in its consideration.

The Intergroup Rhabdomyosarcoma Study-I. A final report.

Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma.

The Intergroup Rhabdomyosarcoma Study-II.

Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: a retrospective European multi-center analysis.

Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

P304

2384-2389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2007.14.7207

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Michael Stevens

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18467730

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

4558625

http://www.w3.org/2001/XMLSchema#string